Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people ...

Research suggests certain medications could help build or maintain muscle during weight loss. Here's how they work & how to ...

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.

The other experimental drug is bimagrumab, which is designed to help patients on weight loss medications from losing too much ...

Eli Lilly reports Phase 3 data showing oral obesity drug orforglipron maintained weight loss after Wegovy or Zepbound, beating placebo.

Eli Lilly seeks FDA approval for orforglipron, a once-daily pill shown in trials to help maintain weight loss after stopping ...

Research shows exposure to cold could trigger brown fat activity, which increases calorie burn. Brown fat burns energy to ...

Lilly’s Attain-Maintain Phase III results show that the oral GLP-1 orforglipron can effectively preserve weight loss after injectable therapy, positioning it as a potential long-term maintenance ...

The study proposes that "swearing, a simple and universally accessible linguistic tool, can function as an effective ...

Doctors explain what diabetes remission really means, why crash diets fail, and how consistent lifestyle changes, early ...

Check out 5 exercise bikes for home, designed for helping you stay consistent with daily workouts in the new year.

Salmon, mackerel, sardines, and trout are rich in omega-3 fatty acids, which lower triglycerides, reduce inflammation, and ...